{{Rsnum
|rsid=2636697
|Gene=PPA2
|Chromosome=4
|position=105376356
|Orientation=plus
|GMAF=0.08953
|Gene_s=PPA2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 93.8 | 5.4 | 0.9
| HCB | 57.7 | 37.2 | 5.1
| JPT | 64.6 | 30.1 | 5.3
| YRI | 100.0 | 0.0 | 0.0
| ASW | 98.2 | 1.8 | 0.0
| CHB | 57.7 | 37.2 | 5.1
| CHD | 52.3 | 42.1 | 5.6
| GIH | 73.3 | 24.8 | 2.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 72.4 | 24.1 | 3.4
| MKK | 0.0 | 0.0 | 0.0
| TSI | 95.1 | 4.9 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23241943
  |Trait=Response to antipsychotic treatment
  |Title=Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment.
  |RiskAllele=G
  |Pval=4E-7
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}